APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Cold Chain Logistics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell and Gene Therapy Cold Chain Logistics Market Outlook and Growth Opportunities 2026

4 March 2026196 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Cold Chain Logistics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Cold Chain Logistics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Cold Chain Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Cold Chain Logistics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Cold Chain Logistics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Cold Chain Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell and Gene Therapy Cold Chain Logistics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell and Gene Therapy Cold Chain Logistics market include AmerisourceBergen Corporation, Arvato Supply Chain Solutions SE, Be The Match BioTherapies, BioLife Solutions, Cardinal Health, Catalent, Cryoport, BioStor Sytems and Marken, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell and Gene Therapy Cold Chain Logistics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy Cold Chain Logistics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy Cold Chain Logistics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell and Gene Therapy Cold Chain Logistics market.

Cell and Gene Therapy Cold Chain Logistics Segment by Company

AmerisourceBergen Corporation

Arvato Supply Chain Solutions SE

Be The Match BioTherapies

BioLife Solutions

Cardinal Health

Catalent

Cryoport

BioStor Sytems

Marken

Polar Express Transportation

Thermo Fisher Scientific

Yourway Biopharma Services Company

Cell and Gene Therapy Cold Chain Logistics Segment by Type

Air Freight

Ground Transportation

Water Transport

Cell and Gene Therapy Cold Chain Logistics Segment by Application

Biopharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

Cell and Gene Therapy Cold Chain Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell and Gene Therapy Cold Chain Logistics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell and Gene Therapy Cold Chain Logistics key companies, revenue, market share, and recent developments.

3. To split the Cell and Gene Therapy Cold Chain Logistics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell and Gene Therapy Cold Chain Logistics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell and Gene Therapy Cold Chain Logistics significant trends, drivers, influence factors in global and regions.

6. To analyze Cell and Gene Therapy Cold Chain Logistics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Cold Chain Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Cold Chain Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Cold Chain Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Cold Chain Logistics industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy Cold Chain Logistics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell and Gene Therapy Cold Chain Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell and Gene Therapy Cold Chain Logistics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell and Gene Therapy Cold Chain Logistics Industry Trends Table 2. Cell and Gene Therapy Cold Chain Logistics Industry Drivers Table 3. Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges Table 4. Cell and Gene Therapy Cold Chain Logistics Industry Restraints Table 5. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell and Gene Therapy Cold Chain Logistics Revenue Share by Company (2021-2026) Table 7. Global Cell and Gene Therapy Cold Chain Logistics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell and Gene Therapy Cold Chain Logistics Key Company Manufacturing Base & Headquarters Table 9. Global Cell and Gene Therapy Cold Chain Logistics Company, Product Type & Application Table 10. Global Cell and Gene Therapy Cold Chain Logistics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell and Gene Therapy Cold Chain Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Air Freight Table 15. Significant Companies of Ground Transportation Table 16. Significant Companies of Water Transport Table 17. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type (2021-2026) Table 21. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biopharmaceutical & Biotechnology Companies Table 23. Significant Companies of Academic & Research Institutes Table 24. Significant Companies of Others Table 25. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application (2021-2026) Table 29. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application (2027-2032) Table 30. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Region (2021-2026) Table 33. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Region (2027-2032) Table 35. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Market Share by Country (2021-2026) Table 38. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Market Share by Country (2027-2032) Table 40. AmerisourceBergen Corporation Company Information Table 41. AmerisourceBergen Corporation Business Overview Table 42. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 44. AmerisourceBergen Corporation Recent Development Table 45. Arvato Supply Chain Solutions SE Company Information Table 46. Arvato Supply Chain Solutions SE Business Overview Table 47. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 49. Arvato Supply Chain Solutions SE Recent Development Table 50. Be The Match BioTherapies Company Information Table 51. Be The Match BioTherapies Business Overview Table 52. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 54. Be The Match BioTherapies Recent Development Table 55. BioLife Solutions Company Information Table 56. BioLife Solutions Business Overview Table 57. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 59. BioLife Solutions Recent Development Table 60. Cardinal Health Company Information Table 61. Cardinal Health Business Overview Table 62. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 64. Cardinal Health Recent Development Table 65. Catalent Company Information Table 66. Catalent Business Overview Table 67. Catalent Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 69. Catalent Recent Development Table 70. Cryoport Company Information Table 71. Cryoport Business Overview Table 72. Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 74. Cryoport Recent Development Table 75. BioStor Sytems Company Information Table 76. BioStor Sytems Business Overview Table 77. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 79. BioStor Sytems Recent Development Table 80. Marken Company Information Table 81. Marken Business Overview Table 82. Marken Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 84. Marken Recent Development Table 85. Polar Express Transportation Company Information Table 86. Polar Express Transportation Business Overview Table 87. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 89. Polar Express Transportation Recent Development Table 90. Thermo Fisher Scientific Company Information Table 91. Thermo Fisher Scientific Business Overview Table 92. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 94. Thermo Fisher Scientific Recent Development Table 95. Yourway Biopharma Services Company Company Information Table 96. Yourway Biopharma Services Company Business Overview Table 97. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 99. Yourway Biopharma Services Company Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Cold Chain Logistics Product Image Figure 2. Global Cell and Gene Therapy Cold Chain Logistics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell and Gene Therapy Cold Chain Logistics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Air Freight Image Figure 8. Ground Transportation Image Figure 9. Water Transport Image Figure 10. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type (2021-2032) Figure 13. Biopharmaceutical & Biotechnology Companies Image Figure 14. Academic & Research Institutes Image Figure 15. Others Image Figure 16. Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application (2021-2032) Figure 19. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Air Freight
  • Ground Transportation
  • Water Transport
Applications
  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
Companies covered
  • AmerisourceBergen Corporation
  • Arvato Supply Chain Solutions SE
  • Be The Match BioTherapies
  • BioLife Solutions
  • Cardinal Health
  • Catalent
  • Cryoport
  • BioStor Sytems
  • Marken
  • Polar Express Transportation
  • Thermo Fisher Scientific
  • Yourway Biopharma Services Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Cold Chain Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Cold Chain Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Cold Chain Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Cold Chain Logistics Industry Restraints
3 Cell and Gene Therapy Cold Chain Logistics Market by Company
  1. 3.1 Global Cell and Gene Therapy Cold Chain Logistics Company Revenue Ranking in 2025
  2. 3.2 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Company (2021-2026)
  3. 3.3 Global Cell and Gene Therapy Cold Chain Logistics Company Ranking (2024-2026)
  4. 3.4 Global Cell and Gene Therapy Cold Chain Logistics Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell and Gene Therapy Cold Chain Logistics Company Product Type and Application
  6. 3.6 Global Cell and Gene Therapy Cold Chain Logistics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell and Gene Therapy Cold Chain Logistics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell and Gene Therapy Cold Chain Logistics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell and Gene Therapy Cold Chain Logistics Market by Type
  1. 4.1 Cell and Gene Therapy Cold Chain Logistics Type Introduction
  2. 4.1.1 Air Freight
  3. 4.1.2 Ground Transportation
  4. 4.1.3 Water Transport
  5. 4.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type
  6. 4.2.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type (2021-2032)
5 Cell and Gene Therapy Cold Chain Logistics Market by Application
  1. 5.1 Cell and Gene Therapy Cold Chain Logistics Application Introduction
  2. 5.1.1 Biopharmaceutical & Biotechnology Companies
  3. 5.1.2 Academic & Research Institutes
  4. 5.1.3 Others
  5. 5.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application
  6. 5.2.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application (2021-2032)
6 Cell and Gene Therapy Cold Chain Logistics Regional Value Analysis
  1. 6.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032)
  7. 6.3.2 North America Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032)
  10. 6.4.2 Europe Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032)
  16. 6.6.2 South America Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Country, 2025 VS 2032
7 Cell and Gene Therapy Cold Chain Logistics Country-level Value Analysis
  1. 7.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell and Gene Therapy Cold Chain Logistics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell and Gene Therapy Cold Chain Logistics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AmerisourceBergen Corporation
  2. 8.1.1 AmerisourceBergen Corporation Company Information
  3. 8.1.2 AmerisourceBergen Corporation Business Overview
  4. 8.1.3 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  6. 8.1.5 AmerisourceBergen Corporation Recent Developments
  7. 8.2 Arvato Supply Chain Solutions SE
  8. 8.2.1 Arvato Supply Chain Solutions SE Company Information
  9. 8.2.2 Arvato Supply Chain Solutions SE Business Overview
  10. 8.2.3 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  12. 8.2.5 Arvato Supply Chain Solutions SE Recent Developments
  13. 8.3 Be The Match BioTherapies
  14. 8.3.1 Be The Match BioTherapies Company Information
  15. 8.3.2 Be The Match BioTherapies Business Overview
  16. 8.3.3 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  18. 8.3.5 Be The Match BioTherapies Recent Developments
  19. 8.4 BioLife Solutions
  20. 8.4.1 BioLife Solutions Company Information
  21. 8.4.2 BioLife Solutions Business Overview
  22. 8.4.3 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  24. 8.4.5 BioLife Solutions Recent Developments
  25. 8.5 Cardinal Health
  26. 8.5.1 Cardinal Health Company Information
  27. 8.5.2 Cardinal Health Business Overview
  28. 8.5.3 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  30. 8.5.5 Cardinal Health Recent Developments
  31. 8.6 Catalent
  32. 8.6.1 Catalent Company Information
  33. 8.6.2 Catalent Business Overview
  34. 8.6.3 Catalent Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  36. 8.6.5 Catalent Recent Developments
  37. 8.7 Cryoport
  38. 8.7.1 Cryoport Company Information
  39. 8.7.2 Cryoport Business Overview
  40. 8.7.3 Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  42. 8.7.5 Cryoport Recent Developments
  43. 8.8 BioStor Sytems
  44. 8.8.1 BioStor Sytems Company Information
  45. 8.8.2 BioStor Sytems Business Overview
  46. 8.8.3 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  48. 8.8.5 BioStor Sytems Recent Developments
  49. 8.9 Marken
  50. 8.9.1 Marken Company Information
  51. 8.9.2 Marken Business Overview
  52. 8.9.3 Marken Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  54. 8.9.5 Marken Recent Developments
  55. 8.10 Polar Express Transportation
  56. 8.10.1 Polar Express Transportation Company Information
  57. 8.10.2 Polar Express Transportation Business Overview
  58. 8.10.3 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  60. 8.10.5 Polar Express Transportation Recent Developments
  61. 8.11 Thermo Fisher Scientific
  62. 8.11.1 Thermo Fisher Scientific Company Information
  63. 8.11.2 Thermo Fisher Scientific Business Overview
  64. 8.11.3 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  66. 8.11.5 Thermo Fisher Scientific Recent Developments
  67. 8.12 Yourway Biopharma Services Company
  68. 8.12.1 Yourway Biopharma Services Company Company Information
  69. 8.12.2 Yourway Biopharma Services Company Business Overview
  70. 8.12.3 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  72. 8.12.5 Yourway Biopharma Services Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst